RxDoctor Payments Data

Timothy Doyle, DO

Family Medicine · Joliet, ILNPI 1548376510

Payments from drug & device makers

$2,401in general payments, 2019–2025

Across 123 payments — averaging $19.52 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Lilly USA, LLC$316
  • Novo Nordisk$296
  • AstraZeneca$289
  • Pfizer$226
  • AbbVie$225
  • Johnson & Johnson$217
  • plus $832 from 16 others

What the payments were for

  • Food & beverage$2,401100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$2,401 in reported general payments places this provider in the 80th percentile of 4,116 family medicine providers in Illinois.

See all family medicine providers in Illinois

Medicare billing

Part B allowed, 2024
$227,259
Medicare patients
455
Services billed
9,615

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
MounjaroTirzepatide44$62,331
EliquisApixaban64$55,658
JanuviaSitagliptin Phosphate46$55,159
OzempicSemaglutide41$48,263
JardianceEmpagliflozin35$42,030
RybelsusSemaglutide16$30,296
TrulicityDulaglutide14$22,468
FarxigaDapagliflozin Propanediol35$22,401
LinzessLinaclotide19$17,490
Breo ElliptaFluticasone/Vilanterol20$11,865
TradjentaLinagliptin13$11,502
Trelegy ElliptaFluticasone/Umeclidin/Vilanter15$11,239
Lantus SolostarInsulin Glargine,hum.Rec.Anlog50$7,144
Levothyroxine Sodium416$5,888
Metoprolol Succinate224$4,263

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCMounjaro, Trulicity$316$84,79958 claims
Novo NordiskOzempic, Rybelsus$296$78,55957 claims
PfizerEliquis$226$55,65864 claims
Boehringer IngelheimJardiance, Tradjenta$49$53,53148 claims
AstraZenecaFarxiga, Symbicort$289$26,11549 claims
GSKBreo Ellipta, Trelegy Ellipta$114$23,10435 claims
AbbVieLinzess, Synthroid$225$19,20155 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 4,116 family medicine providers in Illinois.

Other family medicine in Joliet

See the full list for Illinois

Where these figures come from

Is this you, or does something look wrong? →